Oriental Aromatics Q1 FY27 earnings call

Oriental Aromatics reported a robust start to FY27 with consolidated revenue reaching Rs. 260 crores, marking a 15% year-on-year increase. This growth was primarily volume-driven, with sales volumes up 22% and production volumes up 18% year-on-year, reflecting healthy manufacturing utilization. Sequentially, EBITDA margins improved by 71 basis points to 7.62% from 6.89% in Q4 FY26, attributed to a favorable product mix, improved sales realizations, and operational efficiency programs.

Despite sequential margin improvement, EBITDA margins were marginally lower year-on-year compared to 8.01% in Q1 FY26, mainly due to elevated raw material costs. The company noted that Alpha-Pinene prices, a significant cost contributor, have surged by 70-80% over the past five months and remain high. The industry continues to face competitive pricing pressures, particularly in Specialty Aroma Ingredients due to overcapacity in Asia, making it challenging to pass on increased costs.

The Mahad facility, a long-term strategic investment, is currently operating at 50-60% utilization. While commercial shipments are progressing and customer feedback is encouraging, it has not yet reached the 75-80% utilization level required to absorb its fixed operating costs and become EBITDA positive, thus impacting consolidated profitability. The company aims to progressively increase utilization, acknowledging that inventory buildup has occurred due to production ahead of approvals and raw material challenges.

The Camphor and Terpene Chemicals division saw strong year-on-year volume growth, aligning with seasonal inventory build-up for the festive demand in Q2 and Q3. However, the domestic Camphor market continues to grapple with structural overcapacity from recent manufacturing additions. Management expressed skepticism about industry-wide collaboration to correct pricing due to the limited CAGR of the final product market.

Oriental Aromatics' priorities include sustaining volume growth and market share across all three businesses, improving margins through product mix and cost management, and accelerating customer approvals for Mahad. The company aims for 10-15% sales growth in the next year and expects the effective tax rate to be around 25% for FY27. They emphasize maximizing utilization of existing assets before undertaking new major expansionary investments, while continuing selective R&D.

The company maintained a prudent capital structure, with the net debt-to-equity ratio improving to 0.56x as of June 30, 2026, from 0.58x at March 31, 2026. This reflects a continued commitment to disciplined capital allocation and financial management, leveraging significant investments made over recent years in manufacturing capacity and technical capabilities.